Shopping Cart
- Remove All
- Your shopping cart is currently empty
7030B-C5, a PCSK9 inhibitor (IC50=1.61 μM), effectively reduces plasma cholesterol and triglyceride (TG) levels in vivo, thereby slowing the progression of atherosclerosis. This compound is used in research related to cardiovascular diseases.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | 7030B-C5, a PCSK9 inhibitor (IC50=1.61 μM), effectively reduces plasma cholesterol and triglyceride (TG) levels in vivo, thereby slowing the progression of atherosclerosis. This compound is used in research related to cardiovascular diseases. |
Molecular Weight | 359.38 |
Formula | C17H21N5O4 |
Cas No. | 370871-42-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.